Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mookerjee

Showing results (361-370 of 461) with videos related to

Pageof 47
Sort By:
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 29, 2023
Surgical management of breast fat necrosis: Multi-institutional data analysis of early outcomes and risk factors for complicationsSamuel Knoedler, Leonard Knoedler, Heli Patel, et al.
Indian Heart Journal|July 20, 2010
Antiplatelet drug resistance in patients with recurrent acute coronary syndrome undergoing conservative managementSantanu Guha, Soura Mookerjee, Pradipta Guha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2021
TLR-4 Agonist Induces IFN-γ Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K PathwayNiranjala Gajanayaka, Simon Xin Min Dong, Hamza Ali, et al.
European Journal of Clinical Pharmacology|November 22, 2011
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosisDidier Lebrec, Jaime Bosch, Rajiv Jalan, et al.
NIHR Open Research|February 11, 2025
Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UKHelen Crisp, Oliver Tavabie, Yvanne Enever, et al.
Human Gene Therapy|April 12, 2018
A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction SpecificityKyle Chamberlain, Jalish M Riyad, Tyrone Garnett, et al.
Hepatology (Baltimore, Md.)|October 13, 2017
Cell death markers in patients with cirrhosis and acute decompensationStewart Macdonald, Fausto Andreola, Patrik Bachtiger, et al.
Blood Advances|April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactorsAmanda L Evans, Amanda Dalby, Holly R Foster, et al.
The Lancet. Digital Health|July 22, 2022
Prediction of hospital-onset COVID-19 infections using dynamic networks of patient contact: an international retrospective cohort studyAshleigh Myall, James R Price, Robert L Peach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III)Hans-Joachim Schmoll, David Cunningham, Alberto Sobrero, et al.
Pageof 47

Showing results (361-370 of 461) with videos related to

Sort By:
Pageof 47
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 29, 2023
Surgical management of breast fat necrosis: Multi-institutional data analysis of early outcomes and risk factors for complicationsSamuel Knoedler, Leonard Knoedler, Heli Patel, et al.
Indian Heart Journal|July 20, 2010
Antiplatelet drug resistance in patients with recurrent acute coronary syndrome undergoing conservative managementSantanu Guha, Soura Mookerjee, Pradipta Guha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2021
TLR-4 Agonist Induces IFN-γ Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K PathwayNiranjala Gajanayaka, Simon Xin Min Dong, Hamza Ali, et al.
European Journal of Clinical Pharmacology|November 22, 2011
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosisDidier Lebrec, Jaime Bosch, Rajiv Jalan, et al.
NIHR Open Research|February 11, 2025
Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UKHelen Crisp, Oliver Tavabie, Yvanne Enever, et al.
Human Gene Therapy|April 12, 2018
A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction SpecificityKyle Chamberlain, Jalish M Riyad, Tyrone Garnett, et al.
Hepatology (Baltimore, Md.)|October 13, 2017
Cell death markers in patients with cirrhosis and acute decompensationStewart Macdonald, Fausto Andreola, Patrik Bachtiger, et al.
Blood Advances|April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactorsAmanda L Evans, Amanda Dalby, Holly R Foster, et al.
The Lancet. Digital Health|July 22, 2022
Prediction of hospital-onset COVID-19 infections using dynamic networks of patient contact: an international retrospective cohort studyAshleigh Myall, James R Price, Robert L Peach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III)Hans-Joachim Schmoll, David Cunningham, Alberto Sobrero, et al.
Pageof 47